CD160 Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


CD160 Antibody
Background:
CD160, also known as BY55, is a lipid-anchored cell membrane glycoprotein that contains one immunoglobulin-like domain (1) . It is expressed in small intestine, spleen and functional NK and T cytotoxic lymphocytes (1,2) . CD160 exists as a disulfide-linked homomultimer that functions as a receptor for MHC (major histocompatability complex) molecules and is thought to regulate the function of NK cells (2,3) . Additionally, CD160 interacts with TNFRSF14 and, via this interaction, is able to negatively regulate CD4+ T cell activation, indicating a role in immune system regulation (4) .NCBI Gene ID:
11126Swiss Prot:
O95971Accession Number:
NP_008984Host:
RabbitReactivity:
Human, MouseClonality:
PolyclonalConjugation:
UnconjugatedType:
Primary AntibodiesField of Research:
ImmunologyPurification:
CD160 Antibody is affinity chromatography purified via peptide column.Positive Control:
Cat. No. 1204 - K562 Cell LysateConcentration:
1 mg/mLBuffer:
CD160 Antibody is supplied in PBS containing 0.02% sodium azide.Modification:
NoneShipping Conditions:
Blue IceStorage Conditions:
CD160 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year.Fragment:
IgGSpecificity:
CD160 antibody is human and mouse reactive. Multiple isoforms of CD160 are known to exist.Symbol:
CD160NCBI Official Name:
CD160 moleculeNCBI Organism:
Homo sapiensBackground Reference 01:
Anumanthan A, Bensussan A, Boumsell L, et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 1998; 161:2780-90.Background Reference 02:
Agrawal S, Marquet J, Freeman GJ, et al. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J. Immunol. 1999; 162:1223-6.Background Reference 03:
Le Bouteiller P, Tabiasco J, Polgar B, et al. CD160: a unique activating NK cell receptor. Immunol. Lett. 2011;138:93-6Background Reference 04:
Chabot S, Jabrane-Ferrat N, Bigot K, et al. A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J. Exp. Med. 2011; 208:973-86.Other Product Names:
CD160 Antibody : NK1, BY55, NK28, CD160 antigen, Natural killer cell receptor BY55Tested Applications:
ELISA, WB, IFProtein ID:
5901910Physical Properties:
Liquid
